< Back to catalogue
SeHCAT™
September 9, 2026Sodium Iodide I-123
September 9, 2026PHARMAZAC
AdreView™
Iobenguane (123I) | Molecular Imaging | Radiopharmaceutical
| ADREVIEW INJ.SOL 74MBq/mL BTx1VIALx0,5mL (1mCi – 10mCi/vial) |
| ADREVIEW INJ.SOL 74MBq/mL BTx1VIALx0,5mL (1mCi – 10mCi/vial) |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
